T-cell ligands modulate the cytolytic activity of the CD33/CD3 BiTE antibody construct, AMG 330

Preclinical and emerging clinical studies demonstrate that bispecific T-cell engaging (BiTE) antibody constructs can potently lyse targeted tumor cells, but the determinants for their activity remain incompletely understood. Using human acute myeloid leukemia (AML) cell lines engineered to overexpre...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Blood Cancer J
Main Authors: Laszlo, G S, Gudgeon, C J, Harrington, K H, Walter, R B
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2015
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4558592/
https://ncbi.nlm.nih.gov/pubmed/26295610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2015.68
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki